Refine your #HCM Treatment Strategies with 🎙️Dr Sharlene Day Women As One #CLIMB2024 presents Part 2 of its HCM series 📺👉 https://ow.ly/fy7L50T55uZ Dr Day delves into clinical treatment strategies for hypertrophic cardiomyopathy, including pharmacological management and the significant role of increased exercise in patient care. Stay tuned for more #HF content curated by program directors Dr Bonnie Ky & Dr Clara Saldarriaga! #CardioEd #WIC
Radcliffe Cardiology’s Post
More Relevant Posts
-
ScoliCare prioritizes patient-centered scoliosis treatment. Here are some of the benefits you can expect in our clinics: 🌟Improved Clinical Outcomes 🌟Advanced Technologies 🌟Improved Quality of Life 🌟Enhanced Patient-Provider Relationships Our recent blog talks about the importance of patient-centered treatment. Check it out here: https://lnkd.in/eN96mm9R #Scoliosis #ScoliCare #ScoliBrace
To view or add a comment, sign in
-
The latest Peterson Health Technology Institute (PHTI) Review of Digital MSK Solutions is out, and it's a must-read. Key takeaways: •Findings favour blended platforms over fully digital-only solutions for functional improvements •Digital-only solutions can still show benefits for pain-management •Remote Therapeutic Monitoring (RTM) showed clinical benefits but no financial gains and is suggested for higher-acuity patients Check out the full report for more insights! #DigitalHealth #MSK #HealthcareInnovation #TherapeuticMonitoring #SeriousFunRehab
To view or add a comment, sign in
-
🔊 Tomorrow! Join us to explore the nuances of #anticoagulation therapy in the US. Learn more & register > https://bit.ly/45gYr73 The discussion will focus on the findings of our scoping review in JTT that delves into the differences in the quality of care across ethnoracial groups, as well as valuable insights into how these disparities impact patient outcomes. Our expert panel: Andrea Van Beek, DNP, APRN, AGPCNP-BC, CACP (Moderator) Darren Triller, PharmD (Moderator) Sara Vazquez, PharmD, BCPS, CACP (Presenter) Naomi Yates, PharmD, BCACP (Panelist) Craig Beavers, PharmD, FACC, FAHA,FCCP,BCCP,CACP (Panelist)
To view or add a comment, sign in
-
🔊 Have you registered yet? Join us to explore the nuances of #anticoagulation therapy in the US. Learn more & register > https://bit.ly/45gYr73 The discussion will focus on the findings of our scoping review in JTT that delves into the differences in the quality of care across ethnoracial groups, as well as valuable insights into how these disparities impact patient outcomes. Our expert panel: Andrea Van Beek, DNP, APRN, AGPCNP-BC, CACP (Moderator) Darren Triller, PharmD (Moderator) Sara Vazquez, PharmD, BCPS, CACP (Presenter) Naomi Yates, PharmD, BCACP (Panelist) Craig Beavers, PharmD, FACC, FAHA,FCCP,BCCP,CACP, (Panelist)
To view or add a comment, sign in
-
💊 Empowering Proactive Care: Reducing Costs, Elevating Health with Pharmacogenomics. Exciting new research highlights the powerful impact of pharmacogenomic testing💊 https://lnkd.in/gPdxD5X7 Inpatient and Emergency Department Visits: Pharmacogenomic testing is associated with a 39% reduction, indicating lower utilization in these high-cost areas. Outpatient Visits: There’s a 21% increase, suggesting a shift toward proactive care, likely resulting in improved management of conditions and potential cost savings. To Learn More about how Cygenex is using PGx testing is eliminate Step Therapy and reduce Medical Cost send me a message or visit the link above
To view or add a comment, sign in
-
This is a fantastic example of how our team not just recruits patients, but truly takes the time to get to know them and what they are facing. This is fantastic content, I highly recommend giving it a read! #hemophilia #rarediseaseday2024 #patientcare #casestudy #marketresearch
Case Study Spotlight: Hemophilia A Treatment Evolution Ian Becattelli introduces Hemophlia A case studies, shedding light on the remarkable advancements in treating Hemophilia A, a rare but significant bleeding disorder. In this case study, we discuss the therapeutic milestones, including the pivotal moments that have shaped the landscape of Hemophilia A management. As well as Patient Stories. Hear from individuals impacted by Hemophilia A, sharing their personal experiences navigating treatment options and witnessing transformative changes. 💡 Why This Matters: - Empowering Patients: Understanding the spectrum of treatment options empowers patients and caregivers to make informed decisions, fostering greater autonomy and confidence. - Advancing Medical Science: By dissecting the successes and challenges in Hemophilia A management, we pave the way for further innovation and refinement in therapeutic approaches. Download the compact case study below, for the full case study please contact: ian@just-worldwide.com #HemophiliaA #RareDisease #CaseStudy #PatientCare #HealthcareAdvancement #MarketResearch #HealthcareMarketResearch #LinkedInCaseStudy
To view or add a comment, sign in
-
#APLAR24 Workshop Alert: Bone Densitometry for Clinical Practice Get ready for this insightful and practical session designed to elevate your clinical practice in #bonehealth diagnostics. We will begin with a discussion on the use of DXA and FRAX to guide treatment decisions, equipping you with essential tools and strategies for making informed choices in patient care. Following that, we will explore common issues and pitfalls in DXA interpretation, providing you with the knowledge to identify and avoid errors, ensuring accurate and reliable results. Don't miss this opportunity to enhance your expertise in #bonedensitometry and improve patient outcomes. See the workshop program here: https://lnkd.in/dxg3Yh49 #rheumatology #autoimmunedisease #APLARCongress
To view or add a comment, sign in
-
Case Study Spotlight: Hemophilia A Treatment Evolution Ian Becattelli introduces Hemophlia A case studies, shedding light on the remarkable advancements in treating Hemophilia A, a rare but significant bleeding disorder. In this case study, we discuss the therapeutic milestones, including the pivotal moments that have shaped the landscape of Hemophilia A management. As well as Patient Stories. Hear from individuals impacted by Hemophilia A, sharing their personal experiences navigating treatment options and witnessing transformative changes. 💡 Why This Matters: - Empowering Patients: Understanding the spectrum of treatment options empowers patients and caregivers to make informed decisions, fostering greater autonomy and confidence. - Advancing Medical Science: By dissecting the successes and challenges in Hemophilia A management, we pave the way for further innovation and refinement in therapeutic approaches. Download the compact case study below, for the full case study please contact: ian@just-worldwide.com #HemophiliaA #RareDisease #CaseStudy #PatientCare #HealthcareAdvancement #MarketResearch #HealthcareMarketResearch #LinkedInCaseStudy
To view or add a comment, sign in
-
🔊 Join us for this important webinar exploring the nuances of #anticoagulation therapy in the US. Learn more & register > https://bit.ly/45gYr73 The discussion will focus on the findings of a scoping review that delves into the differences in the quality of care across ethnoracial groups, as well as valuable insights into how these disparities impact patient outcomes. Our expert panel: Andrea Van Beek, DNP, APRN, AGPCNP-BC, CACP (Moderator) Darren Triller, PharmD (Moderator) Sara Vazquez, PharmD, BCPS, CACP (Presenter) Naomi Yates, PharmD, BCACP (Panelist) Craig Beavers, PharmD, FACC, FAHA,FCCP,BCCP,CACP (Panelist)
To view or add a comment, sign in
-
📣 Join us tomorrow at a live Webinar, where we will showcase the Global IMAS Report and discuss what the evidence and calls to action mean for patients and patient organisations. As well as highlighting some of the key results from the report, we will hear clinician and patient organisation perspectives on how IMAS can be used as a tool for change. Please email projectmanager@asif.info to confirm your attendance. Wednesday 13 March - 12:00 to 13:30 GMT #axSpA #rheumatology #rheumatologist #rmds #AxialSpondyloarthritis
Don't miss the IMAS Webinar tomorrow! 13 March, 12:00-13:30 GMT
To view or add a comment, sign in
8,422 followers